Addressing the affordability of cancer drugs: using deliberative public engagement to inform health policy View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2019-12

AUTHORS

Colene Bentley, Stuart Peacock, Julia Abelson, Michael M. Burgess, Olivier Demers-Payette, Holly Longstaff, Laura Tripp, John N. Lavis, Michael G. Wilson

ABSTRACT

BACKGROUND: Health system expenditure on cancer drugs is rising rapidly in many OECD countries given the costly new treatments and increased rates of use due to a growing and ageing population. These factors put considerable strain on the sustainability of health systems worldwide, sparking public debate among clinicians, pharmaceutical companies, policy-makers and citizens on issues of affordability and equity. We engaged Canadians through a series of deliberative public engagement events to determine their priorities for making cancer drug funding decisions fair and sustainable in Canada's publicly financed health system. METHODS: An approach to deliberation was developed based on the McMaster Health Forum's citizen panels and the established Burgess and O'Doherty model of deliberative public engagement. Six deliberations were held across Canada in 2016. Transcripts were coded in NVivo and analysed to determine where participants' views converged and diverged. Recommendations were grouped thematically. RESULTS: A total of 115 Canadians participated in the deliberative events and developed 86 recommendations. Recommendations included the review and regular re-review of approved drugs using 'real-world' evidence on effectiveness and cost-effectiveness; prioritisation of treatments that restore patients' independence, mental health and general well-being; ensuring that decision processes, results and their rationales are transparent; and commitment to people with similar needs receiving the same care regardless of where in Canada they live. CONCLUSIONS: The next steps for policy-makers should be to develop mechanisms for (1) re-reviewing effectiveness and cost-effectiveness data for all cancer drugs; (2) making disinvestments in cancer drugs that satisfy requirements relating to grandfathering and compassionate access; (3) ensuring fair and equitable access to cancer drugs for all Canadians; and (4) fostering a pan-Canadian approach to cancer drug funding decisions. More... »

PAGES

17

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s12961-019-0411-8

DOI

http://dx.doi.org/10.1186/s12961-019-0411-8

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1111989421

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30732616


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1117", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Public Health and Health Services", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "name": [
            "Canadian Centre for Applied Research in Cancer Control (ARCC), 675 West 10th Avenue, V5Z 1L3, Vancouver, British Columbia, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bentley", 
        "givenName": "Colene", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Canadian Centre for Applied Research in Cancer Control (ARCC), 675 West 10th Avenue, V5Z 1L3, Vancouver, British Columbia, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Peacock", 
        "givenName": "Stuart", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "McMaster University", 
          "id": "https://www.grid.ac/institutes/grid.25073.33", 
          "name": [
            "Department of Health Research Methods, Evidence and Impact, McMaster University, 1280 Main Street West (CRL 203), L8S 4K1, Hamilton, Ontario, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Abelson", 
        "givenName": "Julia", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of British Columbia", 
          "id": "https://www.grid.ac/institutes/grid.17091.3e", 
          "name": [
            "School of Population and Public Health, University of British Columbia, 239 RHS, 1088 Discovery Avenue, V1V 1V7, Kelowna, British Columbia, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Burgess", 
        "givenName": "Michael M.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institut National d'Excellence en Sant\u00e9 et en Services Sociaux", 
          "id": "https://www.grid.ac/institutes/grid.493304.9", 
          "name": [
            "Institute National d\u2019Excellence en Sant\u00e9 et en Services Sociaux (INESSS), 2021 avenue Union, 12th Floor, bureau 1200, H3A 2S9, Montreal, Quebec, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Demers-Payette", 
        "givenName": "Olivier", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Engage Associates Consulting Firm, Vancouver, British Columbia, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Longstaff", 
        "givenName": "Holly", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "McMaster University", 
          "id": "https://www.grid.ac/institutes/grid.25073.33", 
          "name": [
            "Department of Health Research Methods, Evidence and Impact, McMaster University, 1280 Main Street West (CRL 203), L8S 4K1, Hamilton, Ontario, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tripp", 
        "givenName": "Laura", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "McMaster Health Forum, 1280 Main Street West, MML-417, L8S 4L6, Ontario, Hamilton, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lavis", 
        "givenName": "John N.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "McMaster Health Forum, 1280 Main Street West, MML-417, L8S 4L6, Ontario, Hamilton, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wilson", 
        "givenName": "Michael G.", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1111/j.1088-4963.1997.tb00082.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005461296"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1470-2045(15)00449-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013873101"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.healthpol.2009.01.005", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014857336"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.socscimed.2011.04.017", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024500110"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3747/co.20.1315", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027115363"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3109/0284186x.2012.739730", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030249009"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.9778/cmajo.20130041", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032255661"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.9778/cmajo.20130041", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032255661"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0168-8510(03)00048-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032374801"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0168-8510(03)00048-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032374801"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2307/3528667", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033366477"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1634/theoncologist.2014-0437", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033717444"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.socscimed.2014.10.038", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041846426"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/978-3-319-32240-7_13", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042079549", 
          "https://doi.org/10.1007/978-3-319-32240-7_13"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.2015.56", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042284414", 
          "https://doi.org/10.1038/bjc.2015.56"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.healthpol.2009.02.006", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045727750"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/hast.26", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046351917"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/0963662512472160", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1063904579"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/0963662512472160", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1063904579"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1257/jep.29.1.139", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064530756"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1078563033", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2019-12", 
    "datePublishedReg": "2019-12-01", 
    "description": "BACKGROUND: Health system expenditure on cancer drugs is rising rapidly in many OECD countries given the costly new treatments and increased rates of use due to a growing and ageing population. These factors put considerable strain on the sustainability of health systems worldwide, sparking public debate among clinicians, pharmaceutical companies, policy-makers and citizens on issues of affordability and equity. We engaged Canadians through a series of deliberative public engagement events to determine their priorities for making cancer drug funding decisions fair and sustainable in Canada's publicly financed health system.\nMETHODS: An approach to deliberation was developed based on the McMaster Health Forum's citizen panels and the established Burgess and O'Doherty model of deliberative public engagement.\u00a0Six deliberations were held across Canada in 2016. Transcripts were coded in NVivo and analysed to determine where participants' views converged and diverged. Recommendations were grouped thematically.\nRESULTS: A total of 115 Canadians participated in the deliberative events and developed 86 recommendations. Recommendations included the review and regular re-review of approved drugs using 'real-world' evidence on effectiveness and cost-effectiveness; prioritisation of treatments that restore patients' independence, mental health and general well-being; ensuring that decision processes, results and their rationales are transparent; and commitment to people with similar needs receiving the same care regardless of where in Canada they live.\nCONCLUSIONS: The next steps for policy-makers should be to develop mechanisms for (1) re-reviewing effectiveness and cost-effectiveness data for all cancer drugs; (2) making disinvestments in cancer drugs that satisfy requirements relating to grandfathering and compassionate access; (3) ensuring fair and equitable access to cancer drugs for all Canadians; and (4) fostering a pan-Canadian approach to cancer drug funding decisions.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/s12961-019-0411-8", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1032049", 
        "issn": [
          "1478-4505"
        ], 
        "name": "Health Research Policy and Systems", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "17"
      }
    ], 
    "name": "Addressing the affordability of cancer drugs: using deliberative public engagement to inform health policy", 
    "pagination": "17", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "1f1a04c0ceb7fca714e5d85a6ac7dc1d005f71ab9baae6fc5e9ded73da67ec84"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30732616"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "101170481"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s12961-019-0411-8"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1111989421"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s12961-019-0411-8", 
      "https://app.dimensions.ai/details/publication/pub.1111989421"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T09:12", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000338_0000000338/records_47985_00000002.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1186%2Fs12961-019-0411-8"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s12961-019-0411-8'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s12961-019-0411-8'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s12961-019-0411-8'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s12961-019-0411-8'


 

This table displays all metadata directly associated to this object as RDF triples.

186 TRIPLES      21 PREDICATES      47 URIs      21 LITERALS      9 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s12961-019-0411-8 schema:about anzsrc-for:11
2 anzsrc-for:1117
3 schema:author N0aebecf5f7a24da0ad386c85a4b0bd4e
4 schema:citation sg:pub.10.1007/978-3-319-32240-7_13
5 sg:pub.10.1038/bjc.2015.56
6 https://app.dimensions.ai/details/publication/pub.1078563033
7 https://doi.org/10.1002/hast.26
8 https://doi.org/10.1016/j.healthpol.2009.01.005
9 https://doi.org/10.1016/j.healthpol.2009.02.006
10 https://doi.org/10.1016/j.socscimed.2011.04.017
11 https://doi.org/10.1016/j.socscimed.2014.10.038
12 https://doi.org/10.1016/s0168-8510(03)00048-4
13 https://doi.org/10.1016/s1470-2045(15)00449-0
14 https://doi.org/10.1111/j.1088-4963.1997.tb00082.x
15 https://doi.org/10.1177/0963662512472160
16 https://doi.org/10.1257/jep.29.1.139
17 https://doi.org/10.1634/theoncologist.2014-0437
18 https://doi.org/10.2307/3528667
19 https://doi.org/10.3109/0284186x.2012.739730
20 https://doi.org/10.3747/co.20.1315
21 https://doi.org/10.9778/cmajo.20130041
22 schema:datePublished 2019-12
23 schema:datePublishedReg 2019-12-01
24 schema:description BACKGROUND: Health system expenditure on cancer drugs is rising rapidly in many OECD countries given the costly new treatments and increased rates of use due to a growing and ageing population. These factors put considerable strain on the sustainability of health systems worldwide, sparking public debate among clinicians, pharmaceutical companies, policy-makers and citizens on issues of affordability and equity. We engaged Canadians through a series of deliberative public engagement events to determine their priorities for making cancer drug funding decisions fair and sustainable in Canada's publicly financed health system. METHODS: An approach to deliberation was developed based on the McMaster Health Forum's citizen panels and the established Burgess and O'Doherty model of deliberative public engagement. Six deliberations were held across Canada in 2016. Transcripts were coded in NVivo and analysed to determine where participants' views converged and diverged. Recommendations were grouped thematically. RESULTS: A total of 115 Canadians participated in the deliberative events and developed 86 recommendations. Recommendations included the review and regular re-review of approved drugs using 'real-world' evidence on effectiveness and cost-effectiveness; prioritisation of treatments that restore patients' independence, mental health and general well-being; ensuring that decision processes, results and their rationales are transparent; and commitment to people with similar needs receiving the same care regardless of where in Canada they live. CONCLUSIONS: The next steps for policy-makers should be to develop mechanisms for (1) re-reviewing effectiveness and cost-effectiveness data for all cancer drugs; (2) making disinvestments in cancer drugs that satisfy requirements relating to grandfathering and compassionate access; (3) ensuring fair and equitable access to cancer drugs for all Canadians; and (4) fostering a pan-Canadian approach to cancer drug funding decisions.
25 schema:genre research_article
26 schema:inLanguage en
27 schema:isAccessibleForFree true
28 schema:isPartOf Ne80e8206c098436e813b808916873b1d
29 Nf235e8be95fa4357a7802f337fbe1a7a
30 sg:journal.1032049
31 schema:name Addressing the affordability of cancer drugs: using deliberative public engagement to inform health policy
32 schema:pagination 17
33 schema:productId N13c6d7f757cd444f8a97cf7343a89225
34 N602e6058394b46cd8a50b76465c99034
35 Nd2cf33dbdf1d47ecb42576cef9e4ca86
36 Neade165db95b4af099e0fe709d4426f1
37 Neb864dd458e141b2a0b52c1cc8dea289
38 schema:sameAs https://app.dimensions.ai/details/publication/pub.1111989421
39 https://doi.org/10.1186/s12961-019-0411-8
40 schema:sdDatePublished 2019-04-11T09:12
41 schema:sdLicense https://scigraph.springernature.com/explorer/license/
42 schema:sdPublisher Na31c76eaac9341cbbc192c09ba0285e8
43 schema:url https://link.springer.com/10.1186%2Fs12961-019-0411-8
44 sgo:license sg:explorer/license/
45 sgo:sdDataset articles
46 rdf:type schema:ScholarlyArticle
47 N027f4432aefd48b39149dbbeb1c77c18 rdf:first Nb554c396b41f49c7b4b69734b674ca72
48 rdf:rest N2e447a6895d849e692f02e0513413a7b
49 N0aebecf5f7a24da0ad386c85a4b0bd4e rdf:first N302b42260632428db5c741c135338989
50 rdf:rest N710dbe968a8943cfabce20ff83fbaeff
51 N111288a99dec4ed9b6334ed08c2a8586 rdf:first N9683f2bf3c3c41eea6dacea14eca57f2
52 rdf:rest rdf:nil
53 N13c6d7f757cd444f8a97cf7343a89225 schema:name pubmed_id
54 schema:value 30732616
55 rdf:type schema:PropertyValue
56 N168fbcdbd0304a04893f5c7cde3eefa6 schema:affiliation N4fbafa047ad14db6a6226316b59273b6
57 schema:familyName Longstaff
58 schema:givenName Holly
59 rdf:type schema:Person
60 N25b4bc494ae24de9b1046b39a1e002a7 rdf:first N8e245d41c1404ef19949241de7d6bad2
61 rdf:rest N3fc8f7000a704954b395771181f13966
62 N2e447a6895d849e692f02e0513413a7b rdf:first N168fbcdbd0304a04893f5c7cde3eefa6
63 rdf:rest Nbdff16b2378841b1a953c7c34518a4bf
64 N302b42260632428db5c741c135338989 schema:affiliation N64b9146836334e6bbe0c35e7a7c09c94
65 schema:familyName Bentley
66 schema:givenName Colene
67 rdf:type schema:Person
68 N322f076ff25c4aad85d1c777b823bd7d schema:affiliation Ndd7b4eac60fb4908b1d0f514b3f6d645
69 schema:familyName Lavis
70 schema:givenName John N.
71 rdf:type schema:Person
72 N3fc8f7000a704954b395771181f13966 rdf:first Na4c409cfa3474e3db1283bef87f8162e
73 rdf:rest N027f4432aefd48b39149dbbeb1c77c18
74 N4fbafa047ad14db6a6226316b59273b6 schema:name Engage Associates Consulting Firm, Vancouver, British Columbia, Canada
75 rdf:type schema:Organization
76 N602e6058394b46cd8a50b76465c99034 schema:name dimensions_id
77 schema:value pub.1111989421
78 rdf:type schema:PropertyValue
79 N64b9146836334e6bbe0c35e7a7c09c94 schema:name Canadian Centre for Applied Research in Cancer Control (ARCC), 675 West 10th Avenue, V5Z 1L3, Vancouver, British Columbia, Canada
80 rdf:type schema:Organization
81 N710dbe968a8943cfabce20ff83fbaeff rdf:first Ne1c82652abd448519badaa41a76615ce
82 rdf:rest N25b4bc494ae24de9b1046b39a1e002a7
83 N8e245d41c1404ef19949241de7d6bad2 schema:affiliation https://www.grid.ac/institutes/grid.25073.33
84 schema:familyName Abelson
85 schema:givenName Julia
86 rdf:type schema:Person
87 N9683f2bf3c3c41eea6dacea14eca57f2 schema:affiliation Ne8251c14233049e2976df1ab333d9363
88 schema:familyName Wilson
89 schema:givenName Michael G.
90 rdf:type schema:Person
91 Na31c76eaac9341cbbc192c09ba0285e8 schema:name Springer Nature - SN SciGraph project
92 rdf:type schema:Organization
93 Na4c409cfa3474e3db1283bef87f8162e schema:affiliation https://www.grid.ac/institutes/grid.17091.3e
94 schema:familyName Burgess
95 schema:givenName Michael M.
96 rdf:type schema:Person
97 Nb554c396b41f49c7b4b69734b674ca72 schema:affiliation https://www.grid.ac/institutes/grid.493304.9
98 schema:familyName Demers-Payette
99 schema:givenName Olivier
100 rdf:type schema:Person
101 Nbdff16b2378841b1a953c7c34518a4bf rdf:first Ne0e82125e46642739c0d2475d97a2116
102 rdf:rest Ncdd2456518a3419db639f3672c9ee512
103 Ncbd6143aa9204aa488aa9e688a3f2e65 schema:name Canadian Centre for Applied Research in Cancer Control (ARCC), 675 West 10th Avenue, V5Z 1L3, Vancouver, British Columbia, Canada
104 rdf:type schema:Organization
105 Ncdd2456518a3419db639f3672c9ee512 rdf:first N322f076ff25c4aad85d1c777b823bd7d
106 rdf:rest N111288a99dec4ed9b6334ed08c2a8586
107 Nd2cf33dbdf1d47ecb42576cef9e4ca86 schema:name readcube_id
108 schema:value 1f1a04c0ceb7fca714e5d85a6ac7dc1d005f71ab9baae6fc5e9ded73da67ec84
109 rdf:type schema:PropertyValue
110 Ndd7b4eac60fb4908b1d0f514b3f6d645 schema:name McMaster Health Forum, 1280 Main Street West, MML-417, L8S 4L6, Ontario, Hamilton, Canada
111 rdf:type schema:Organization
112 Ne0e82125e46642739c0d2475d97a2116 schema:affiliation https://www.grid.ac/institutes/grid.25073.33
113 schema:familyName Tripp
114 schema:givenName Laura
115 rdf:type schema:Person
116 Ne1c82652abd448519badaa41a76615ce schema:affiliation Ncbd6143aa9204aa488aa9e688a3f2e65
117 schema:familyName Peacock
118 schema:givenName Stuart
119 rdf:type schema:Person
120 Ne80e8206c098436e813b808916873b1d schema:volumeNumber 17
121 rdf:type schema:PublicationVolume
122 Ne8251c14233049e2976df1ab333d9363 schema:name McMaster Health Forum, 1280 Main Street West, MML-417, L8S 4L6, Ontario, Hamilton, Canada
123 rdf:type schema:Organization
124 Neade165db95b4af099e0fe709d4426f1 schema:name nlm_unique_id
125 schema:value 101170481
126 rdf:type schema:PropertyValue
127 Neb864dd458e141b2a0b52c1cc8dea289 schema:name doi
128 schema:value 10.1186/s12961-019-0411-8
129 rdf:type schema:PropertyValue
130 Nf235e8be95fa4357a7802f337fbe1a7a schema:issueNumber 1
131 rdf:type schema:PublicationIssue
132 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
133 schema:name Medical and Health Sciences
134 rdf:type schema:DefinedTerm
135 anzsrc-for:1117 schema:inDefinedTermSet anzsrc-for:
136 schema:name Public Health and Health Services
137 rdf:type schema:DefinedTerm
138 sg:journal.1032049 schema:issn 1478-4505
139 schema:name Health Research Policy and Systems
140 rdf:type schema:Periodical
141 sg:pub.10.1007/978-3-319-32240-7_13 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042079549
142 https://doi.org/10.1007/978-3-319-32240-7_13
143 rdf:type schema:CreativeWork
144 sg:pub.10.1038/bjc.2015.56 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042284414
145 https://doi.org/10.1038/bjc.2015.56
146 rdf:type schema:CreativeWork
147 https://app.dimensions.ai/details/publication/pub.1078563033 schema:CreativeWork
148 https://doi.org/10.1002/hast.26 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046351917
149 rdf:type schema:CreativeWork
150 https://doi.org/10.1016/j.healthpol.2009.01.005 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014857336
151 rdf:type schema:CreativeWork
152 https://doi.org/10.1016/j.healthpol.2009.02.006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045727750
153 rdf:type schema:CreativeWork
154 https://doi.org/10.1016/j.socscimed.2011.04.017 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024500110
155 rdf:type schema:CreativeWork
156 https://doi.org/10.1016/j.socscimed.2014.10.038 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041846426
157 rdf:type schema:CreativeWork
158 https://doi.org/10.1016/s0168-8510(03)00048-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032374801
159 rdf:type schema:CreativeWork
160 https://doi.org/10.1016/s1470-2045(15)00449-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013873101
161 rdf:type schema:CreativeWork
162 https://doi.org/10.1111/j.1088-4963.1997.tb00082.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1005461296
163 rdf:type schema:CreativeWork
164 https://doi.org/10.1177/0963662512472160 schema:sameAs https://app.dimensions.ai/details/publication/pub.1063904579
165 rdf:type schema:CreativeWork
166 https://doi.org/10.1257/jep.29.1.139 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064530756
167 rdf:type schema:CreativeWork
168 https://doi.org/10.1634/theoncologist.2014-0437 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033717444
169 rdf:type schema:CreativeWork
170 https://doi.org/10.2307/3528667 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033366477
171 rdf:type schema:CreativeWork
172 https://doi.org/10.3109/0284186x.2012.739730 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030249009
173 rdf:type schema:CreativeWork
174 https://doi.org/10.3747/co.20.1315 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027115363
175 rdf:type schema:CreativeWork
176 https://doi.org/10.9778/cmajo.20130041 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032255661
177 rdf:type schema:CreativeWork
178 https://www.grid.ac/institutes/grid.17091.3e schema:alternateName University of British Columbia
179 schema:name School of Population and Public Health, University of British Columbia, 239 RHS, 1088 Discovery Avenue, V1V 1V7, Kelowna, British Columbia, Canada
180 rdf:type schema:Organization
181 https://www.grid.ac/institutes/grid.25073.33 schema:alternateName McMaster University
182 schema:name Department of Health Research Methods, Evidence and Impact, McMaster University, 1280 Main Street West (CRL 203), L8S 4K1, Hamilton, Ontario, Canada
183 rdf:type schema:Organization
184 https://www.grid.ac/institutes/grid.493304.9 schema:alternateName Institut National d'Excellence en Santé et en Services Sociaux
185 schema:name Institute National d’Excellence en Santé et en Services Sociaux (INESSS), 2021 avenue Union, 12th Floor, bureau 1200, H3A 2S9, Montreal, Quebec, Canada
186 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...